Wolverine Trading
EDIT icon

Wolverine Trading’s Editas Medicine EDIT Stock Holding History

Wolverine Trading’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-139,000
Closed -$317K – 5752
2025
Q2 		$317K Buy
139,000
+82,800
+147% +$135K ﹤0.01% 3422
2025
Q1 		$70.3K Buy
56,200
+16,600
+42% +$24.4K ﹤0.01% 4326
2024
Q4 		$47.5K Buy
39,600
+14,700
+59% +$37.5K ﹤0.01% 4996
2024
Q3 		$86.7K Sell
24,900
-8,600
-26% -$37.4K ﹤0.01% 4398
2024
Q2 		$156K Sell
33,500
-2,000
-6% -$11.3K ﹤0.01% 3932
2024
Q1 		$263K Sell
35,500
-31,800
-47% -$264K ﹤0.01% 3508
2023
Q4 		$682K Buy
67,300
+20,100
+43% +$176K ﹤0.01% 2639
2023
Q3 		$368K Sell
47,200
-6,800
-13% -$58.3K ﹤0.01% 3088
2023
Q2 		$440K Buy
+54,000
New +$470K ﹤0.01% 2727
2023
Q1 		– Sell
-56,100
Closed -$498K – 4418
2022
Q4 		$498K Sell
56,100
-7,600
-12% -$83.4K ﹤0.01% 2335
2022
Q3 		$775K Buy
63,700
+10,900
+21% +$170K ﹤0.01% 2200
2022
Q2 		$646K Sell
52,800
-900
-2% -$12.1K ﹤0.01% 2296
2022
Q1 		$1.05M Buy
53,700
+1,100
+2% +$20.4K ﹤0.01% 2393
2021
Q4 		$1.46M Sell
52,600
-50,100
-49% -$1.72M ﹤0.01% 2199
2021
Q3 		$4.37M Buy
102,700
+50,000
+95% +$2.74M ﹤0.01% 1409
2021
Q2 		$2.43M Buy
52,700
+15,300
+41% +$565K ﹤0.01% 1783
2021
Q1 		$1.51M Sell
37,400
-39,100
-51% -$2.23M ﹤0.01% 2244
2020
Q4 		$5.85M Buy
+76,500
New +$3.14M 0.01% 965
2020
Q3 		– Sell
-40,900
Closed -$1.2M – 4652
2020
Q2 		$1.2M Buy
40,900
+4,300
+12% +$112K ﹤0.01% 1832
2020
Q1 		$741K Sell
36,600
-12,700
-26% -$320K ﹤0.01% 2226
2019
Q4 		$1.45M Buy
49,300
+13,700
+38% +$342K ﹤0.01% 2078
2019
Q3 		$800K Sell
35,600
-7,600
-18% -$188K ﹤0.01% 2161
2019
Q2 		$1.07M Sell
43,200
-16,500
-28% -$394K ﹤0.01% 1982
2019
Q1 		$1.46M Buy
59,700
+27,800
+87% +$629K ﹤0.01% 1775
2018
Q4 		$661K Buy
31,900
+10,300
+48% +$280K ﹤0.01% 2368
2018
Q3 		$687K Buy
+21,600
New +$698K ﹤0.01% 2742

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Wolverine Trading's EDIT Position: Q2 2025 in Review

Wolverine Trading sold out of Editas Medicine (EDIT) in Q2 2025, closing a stake of 11,527 shares — an estimated $18.9K sold.

Wolverine Trading first reported a position in EDIT in Q2 2019 and held it in 14 quarters. The position peaked at $1.69M in Q1 2021. 193 funds tracked by Wall St. Rank hold EDIT as of Q2 2025.

  • Wolverine Trading reported no remaining Editas Medicine position as of Q2 2025 after selling out during the quarter.
  • Wolverine Trading sold 11,527 Editas Medicine shares in Q2 2025, an estimated $18.9K.
  • Wolverine Trading first reported a position in Editas Medicine in Q2 2019 and held it in 14 quarters.
  • Wolverine Trading's Editas Medicine position peaked at $1.69M in Q1 2021.
  • 193 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2025.

Based on Wolverine Trading's 13F filing for Q2 2025, filed 18 Aug 2025.